Matrix-Bound PAI-1 Supports Cell Blebbing via RhoA/ROCK1 Signaling

被引:26
作者
Cartier-Michaud, Amandine [1 ]
Malo, Michel [1 ]
Charriere-Bertrand, Cecile [1 ,2 ]
Gadea, Gilles [3 ]
Anguille, Christelle [3 ]
Supiramaniam, Ajitha [1 ]
Lesne, Annick [4 ,5 ]
Delaplace, Franck [1 ]
Hutzler, Guillaume [1 ]
Roux, Pierre [3 ]
Lawrence, Daniel A. [6 ]
Barlovatz-Meimon, Georgia [1 ,2 ]
机构
[1] Evry Val Essonne Univ, IBISC EA 4526, Evry, France
[2] Univ Paris Est Creteil, Creteil, France
[3] Univ Montpellier, CRBM UMR CNRS 5237, F-34059 Montpellier, France
[4] Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France
[5] LPTMC UMR 7600 CNRS, Paris, France
[6] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; RECEPTOR-RELATED PROTEIN; UROKINASE RECEPTOR; IN-VIVO; EPITHELIAL-CELLS; HUMAN CARCINOMA; RHO-KINASE; MIGRATION; CANCER; VITRONECTIN;
D O I
10.1371/journal.pone.0032204
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The microenvironment of a tumor can influence both the morphology and the behavior of cancer cells which, in turn, can rapidly adapt to environmental changes. Increasing evidence points to the involvement of amoeboid cell migration and thus of cell blebbing in the metastatic process; however, the cues that promote amoeboid cell behavior in physiological and pathological conditions have not yet been clearly identified. Plasminogen Activator Inhibitor type-1 (PAI-1) is found in high amount in the microenvironment of aggressive tumors and is considered as an independent marker of bad prognosis. Here we show by immunoblotting, activity assay and immunofluorescence that, in SW620 human colorectal cancer cells, matrix-associated PAI-1 plays a role in the cell behavior needed for amoeboid migration by maintaining cell blebbing, localizing PDK1 and ROCK1 at the cell membrane and maintaining the RhoA/ROCK1/MLC-P pathway activation. The results obtained by modeling PAI-1 deposition around tumors indicate that matrix-bound PAI-1 is heterogeneously distributed at the tumor periphery and that, at certain spots, the elevated concentrations of matrix-bound PAI-1 needed for cancer cells to undergo the mesenchymal-amoeboid transition can be observed. Matrix-bound PAI-1, as a matricellular protein, could thus represent one of the physiopathological requirements to support metastatic formation.
引用
收藏
页数:12
相关论文
共 57 条
[1]   Vitronectin in human breast carcinomas [J].
Aaboe, M ;
Offersen, BV ;
Christensen, A ;
Andreasen, PA .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1638 (01) :72-82
[2]   Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? [J].
Alan Maxwell, Christopher ;
McCarthy, James ;
Turley, Eva .
JOURNAL OF CELL SCIENCE, 2008, 121 (07) :925-932
[3]   Evolving role of uPA/uPAR system in human cancers [J].
Ass, Kathleen ;
Ahmad, Aamir ;
Azmi, Asfar S. ;
Sarkar, Sarah H. ;
Sarkar, Fazlul H. .
CANCER TREATMENT REVIEWS, 2008, 34 (02) :122-136
[4]   Reassembly of contractile actin cortex in cell blebs [J].
Charras, Guillaume T. ;
Hu, Chi-Kuo ;
Coughlin, Margaret ;
Mitchison, Timothy J. .
JOURNAL OF CELL BIOLOGY, 2006, 175 (03) :477-490
[5]   Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations [J].
Chazaud, B ;
Ricoux, R ;
Christov, C ;
Plonquet, A ;
Gherardi, RK ;
Barlovatz-Meimon, G .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (01) :237-246
[6]  
Chorostowska-Wynimko J, 2004, INT J MOL MED, V13, P759
[7]   RECEPTOR-MEDIATED INTERNALIZATION AND DEGRADATION OF UROKINASE IS CAUSED BY ITS SPECIFIC INHIBITOR PAI-1 [J].
CUBELLIS, MV ;
WUN, TC ;
BLASI, F .
EMBO JOURNAL, 1990, 9 (04) :1079-1085
[8]   Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins [J].
Czekay, RP ;
Aertgeerts, K ;
Curriden, SA ;
Loskutoff, DJ .
JOURNAL OF CELL BIOLOGY, 2003, 160 (05) :781-791
[9]   Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity [J].
Czekay, RP ;
Kuemmel, TA ;
Orlando, RA ;
Farquhar, MG .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (05) :1467-1479
[10]   Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? [J].
Deng, G ;
Curriden, SA ;
Wang, SJ ;
Rosenberg, S ;
Loskutoff, DJ .
JOURNAL OF CELL BIOLOGY, 1996, 134 (06) :1563-1571